Pfizer remains a strong Buy with robust cost controls, EPS growth, and a promising pipeline, despite challenges. See more on ...

The deal prepares for a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from ...

Under the terms of the clinical trial collaboration and supply agreement, Coherus will provide LOQTORZI to STORM, which will be the sponsor of the Phase 1b/2 clinical combination trial. STORM and ...

JNJ's 62-year streak of dividend growth, 3.4% yield, and disciplined capital allocation make it highly attractive for ...

Master data science in 2025. Complete guide to machine learning, big data analytics, Python programming, statistical modeling ...

Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...

President Donald Trump's pro-energy policies were meant to speed the construction of the United States' next generation of ...

In 2025, cybersecurity is an organization-wide priority, which especially includes sales teams. Sales teams handle sensitive data every day—client contacts, contracts, pricing, and deal information.